Welcome to the Garrod Association

admin - Wednesday, 21 April 2010 03:58

Membership: 2017 Membership Application Form

Contact Us: Please email vchaumont@cheo.on.ca with your questions or comments so they may be directed to the appropriate person.  Thank you.

………………………………………………………………………………………………………..

The 2019 GARROD Symposium will be held from May 9 – 11, 2019 at The Sheraton Centre.

More information will be available in late September. If you wish to get on a mailing list to receive updates for this symposium, please contact jo.ipce@ubc.ca

Registration and Brochure available soon

Registration for the event not yet open

Location and Accommodation

The Sheraton Centre, Toronto, ON
123 Queen Street West
Toronto, Ontario M5H 2M9

Details on rooms blocks and rates are not yet available.

Link to photos from the 2016 meeting
Link to videos fro the 2016 meeting
Link to photos from the 2015 meeting
Final report from the 2015 meeting

………………………………………………………………………………………………………..

An International Registry for Morquio-B Disease hosted at BC Children’s Hospital

Morquio-B-Disease is an ultra-rare form of late-onset GM1-Gangliosidosis, characterized by bone disease resembling Morquio-A Disease.

Various research consortia are currently developing treatments for this condition.

Funding from the Priest Family Foundation (www.morquiob.com) allows us to collect natural history data, which will be most essential for the future design of clinical trials.

If you have patients with Morquio-B-Disease or with late-onset GM1-Gangliosidosis, please contact us.

Every single patient is important.

Sylvia Stockler (PI) sstockler@cw.bc.ca

Maria Boldut (Project Manager) maria.boldut@cw.bc.ca

………………………………………………………………………………………………………..

Rare Diseases: Models & Mechanisms Network

Have you identified a new genetic disease or work on a genetic disease which would merit further research in a model organism? If so, please consult http://rare-diseases-catalyst-network.ca for funding and collaboration opportunities. Letter of Information

………………………………………………………………………………………………………..

Seeking Farber Disease or SMA-PME Patients

Plexcera Therapeutics LLC, a biotech firm which is developing an enzyme replacement therapy for acid ceramidase deficiency, is seeking Farber Disease patients to be part of a clinical trial to commence tentatively in the second half of 2015.

Dr. Alexander Solyom, MD, working with Plexcera, is collecting natural history data on SMA-PME patients and coordinating an international natural history study of Farber Disease including non-transplanted, transplanted, and patients since deceased.

Please contact him for further information at patients@plexcera.com